The China-Singapore (Chongqing) Demonstration Initiative on Strategic Connectivity Think Tank, Chongqing 400043, China; Institute for Health Innovation and Technology (iHealthtech), National University of Singapore, Singapore 119077, Singapore.
The First People's Hospital of Chongqing Liang Jiang New Area, Chongqing, China.
Brain Behav Immun. 2020 Jul;87:84-92. doi: 10.1016/j.bbi.2020.04.055. Epub 2020 Apr 23.
This study aimed to quantify the immediate psychological effects and psychoneuroimmunity prevention measures of a workforce returning to work during the COVID-19 epidemic. Workforce returning to work was invited to complete an online questionnaire regarding their attitude toward the COVID-19 epidemic and return-to-work along with psychological parameters including the Impact of Event Scale-Revised, Depression, Anxiety, Stress Scale- 21 (DASS-21) and Insomnia Severity Index (ISI). Psychoneuroimmunity prevention measures include precautions at personal and organization levels. From 673 valid questionnaires, we found that 10.8% of respondents met the diagnosis of post-traumatic stress disorder (PTSD) after returning to work. The respondents reported a low prevalence of anxiety (3.8%), depression (3.7%), stress (1.5%) and insomnia (2.3%). There were no significant differences in the severity of psychiatric symptoms between workers/technicians and executives/managers. >95% reported psychoneuroimmunity prevention measures including good ventilation in the workplace and wore a face mask as protective. Factors that were associated with the severity of psychiatric symptoms in the workforce were marital status, presence of physical symptom, poor physical health and viewing return to work as a health hazard (p < 0.05). In contrast, personal psychoneuroimmunity prevention measures including hand hygiene and wearing face masks as well as organizational measures including significant improvement of workplace hygiene and concerns from the company were associated with less severe psychiatric symptoms (p < 0.05). Contrary to expectations, returning to work had not caused a high level of psychiatric symptoms in the workforce. The low prevalence of psychiatric symptoms could be due to confidence instilled by psychoneuroimmunity prevention measures before the resumption of work. Our findings would provide information for other countries during the COVID-19 pandemic.
本研究旨在量化 COVID-19 疫情期间劳动力重返工作岗位的即时心理影响和心理神经免疫预防措施。邀请重返工作岗位的劳动力完成一份关于他们对 COVID-19 疫情和重返工作岗位的态度以及包括修订后的事件影响量表（IES-R）、抑郁、焦虑、压力量表-21（DASS-21）和失眠严重指数（ISI）在内的心理参数的在线问卷。心理神经免疫预防措施包括个人和组织层面的预防措施。从 673 份有效问卷中，我们发现 10.8%的受访者在重返工作岗位后符合创伤后应激障碍（PTSD）的诊断标准。受访者报告焦虑（3.8%）、抑郁（3.7%）、压力（1.5%）和失眠（2.3%）的患病率较低。工人/技术人员和管理人员之间的精神症状严重程度没有显著差异。>95%的人报告了心理神经免疫预防措施，包括工作场所良好的通风和戴口罩作为保护。与劳动力严重精神症状相关的因素包括婚姻状况、身体症状、身体健康状况不佳以及将重返工作视为健康危害（p<0.05）。相反，个人心理神经免疫预防措施，包括手部卫生和戴口罩，以及组织措施，包括显著改善工作场所卫生和公司的关注，与较轻的精神症状相关（p<0.05）。与预期相反，重返工作岗位并没有在劳动力中引起高水平的精神症状。精神症状的低患病率可能是由于重返工作前心理神经免疫预防措施所带来的信心。我们的研究结果将为其他国家在 COVID-19 大流行期间提供信息。
